Prime Medicine Inc. (PRME)
2.39
-0.13 (-5.16%)
At close: Mar 03, 2025, 12:16 PM
Prime Medicine Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
| Revenue | 2.98M | n/a | n/a | n/a | 5.21M | n/a |
| Cost of Revenue | n/a | 147.91M | n/a | n/a | n/a | 2.76M |
| Gross Profit | 2.98M | -147.91M | n/a | n/a | n/a | -2.76M |
| Operating Income | -202.47M | -191.29M | -116.54M | -84.47M | -932K | -2.17M |
| Interest Income | 3.52M | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -195.88M | -198.41M | -122.77M | -165.85M | -1.54M | -2.52M |
| Net Income | -195.88M | -198.13M | -121.82M | -165.37M | -3.41M | -2.53M |
| Selling & General & Admin | 50.16M | 38.73M | 29.82M | 13.92M | 3.16M | 1.25M |
| Research & Development | 155.29M | 147.91M | 86.72M | 70.55M | 2.98M | 920K |
| Other Expenses | n/a | n/a | 1.9M | -80.99M | -11.48M | n/a |
| Operating Expenses | 205.45M | 186.64M | 116.54M | 84.47M | 6.14M | 2.17M |
| Interest Expense | n/a | n/a | 12.13M | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | -4.65M | n/a | n/a | n/a | 1.25M |
| Cost & Expenses | 205.45M | 191.29M | 116.54M | 84.47M | 6.14M | 2.17M |
| Income Tax | n/a | -279K | -948K | -486K | 1.87M | 4K |
| Shares Outstanding (Basic) | 118.6M | 90.97M | 97.21M | 64.9M | 71.8M | 95.73M |
| Shares Outstanding (Diluted) | 118.6M | 90.97M | 97.21M | 64.9M | 71.8M | 95.73M |
| EPS (Basic) | -1.65 | -2.18 | -1.25 | -2.55 | -0.07 | -0.03 |
| EPS (Diluted) | -1.65 | -2.18 | -1.25 | -2.55 | -0.07 | -0.03 |
| EBITDA | -202.47M | -193.76M | -110.75M | -160.99M | -889K | -2.17M |
| Depreciation & Amortization | n/a | 4.65M | 12.01M | 4.86M | 43K | 6.52M |